TELA Bio (TELA) Receivables - Net (2018 - 2026)

TELA Bio has reported Receivables - Net for 9 years, with the latest figure at $9.6 million in Q2 2026.

• On a quarterly basis, Receivables - Net fell 14.23% year-over-year to $9.6 million in Q2 2026; TTM through Jun 2026 was $9.6 million, a 14.23% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, up 2.47% from the prior year.
• Receivables - Net was $9.6 million for Q2 2026 at TELA Bio, down from $9.7 million in the prior quarter.
• The five-year high for Receivables - Net was $11.3 million in Q3 2025, with the low at $4.3 million in Q1 2022.
• Average Receivables - Net over 5 years is $8.7 million, with a median of $9.7 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2026: Receivables - Net surged 59.19% in 2022, then dropped 14.23% in 2026.
• Over 5 years, Receivables - Net stood at $6.6 million in 2022, then surged by 47.06% to $9.7 million in 2023, then increased by 3.71% to $10.1 million in 2024, then advanced by 2.47% to $10.3 million in 2025, then slipped by 6.86% to $9.6 million in 2026.
• The last three Receivables - Net figures came in at $9.6 million (Q2 2026), $9.7 million (Q1 2026), and $10.3 million (Q4 2025), per Business Quant data.